Jump Financial’s BeOne Medicines Ltd ONC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
– Sell
-70,300
Closed -$17M – 2331
2025
Q2
$17M Sell
70,300
-11,900
-14% -$2.92M 0.18% 124
2025
Q1
$22.4M Buy
82,200
+72,774
+772% +$17M 0.3% 85
2024
Q4
$1.74M Buy
+9,426
New +$1.93M 0.04% 558
2024
Q1
– Sell
-1,961
Closed -$354K – 2381
2023
Q4
$354K Buy
+1,961
New +$355K 0.01% 1244
2023
Q3
– Sell
-1,720
Closed -$307K – 2329
2023
Q2
$307K Buy
+1,720
New +$396K 0.01% 1286
2021
Q1
– Sell
-908
Closed -$235K – 1356
2020
Q4
$235K Buy
+908
New +$250K 0.04% 703

Other funds holding ONC

Jump Financial's ONC Position: Q3 2025 in Review

Jump Financial sold out of BeOne Medicines Ltd (ONC) in Q3 2025, closing a stake of 70,300 shares — an estimated $17M sold.

Jump Financial first reported a position in ONC in Q4 2020 and held it in 6 quarters. The position peaked at $22.4M in Q1 2025. 266 funds tracked by Wall St. Rank hold ONC as of Q3 2025.

  • Jump Financial reported no remaining BeOne Medicines Ltd position as of Q3 2025 after selling out during the quarter.
  • Jump Financial sold 70,300 BeOne Medicines Ltd shares in Q3 2025, an estimated $17M.
  • Jump Financial first reported a position in BeOne Medicines Ltd in Q4 2020 and held it in 6 quarters.
  • Jump Financial's BeOne Medicines Ltd position peaked at $22.4M in Q1 2025.
  • 266 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q3 2025.

Based on Jump Financial's 13F filing for Q3 2025, filed 13 Nov 2025.